Variant report
Variant | nsv469947 |
---|---|
Chromosome Location | chr11:25701663-25730008 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:25709860..25710784-chr18:64774033..64774666,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7930199 | chr11:25701663-25701664 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs200547281 | chr11:25701686-25701687 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs11028844 | chr11:25701873-25701874 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs571404922 | chr11:25701880-25701881 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs538831740 | chr11:25702020-25702021 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs139484133 | chr11:25702038-25702039 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs565820568 | chr11:25702077-25702078 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs569888155 | chr11:25702102-25702103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs558950641 | chr11:25702110-25702111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs554571707 | chr11:25702129-25702130 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs192655756 | chr11:25702134-25702135 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs543452791 | chr11:25702172-25702173 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs60229534 | chr11:25702178-25702179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs57182035 | chr11:25702222-25702223 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs201381792 | chr11:25702228-25702229 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs374637566 | chr11:25702233-25702234 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs34106414 | chr11:25702238-25702239 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs541213922 | chr11:25702252-25702253 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs990473 | chr11:25702271-25702272 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs78205148 | chr11:25702301-25702302 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs73435211 | chr11:25702322-25702323 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs113172619 | chr11:25702324-25702325 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs531157703 | chr11:25702327-25702328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs542459831 | chr11:25702368-25702369 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs563834489 | chr11:25702385-25702386 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs531322818 | chr11:25702464-25702465 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs74331017 | chr11:25702503-25702504 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs571342121 | chr11:25702562-25702563 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs372152411 | chr11:25702594-25702595 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs148856065 | chr11:25702599-25702600 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs145331869 | chr11:25702608-25702609 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs565821223 | chr11:25702610-25702611 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs536067753 | chr11:25702612-25702613 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs77081367 | chr11:25702627-25702628 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs569900271 | chr11:25702639-25702640 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs536698969 | chr11:25702646-25702647 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs537028185 | chr11:25702661-25702662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs558564424 | chr11:25702663-25702664 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs370078361 | chr11:25702673-25702674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs576845445 | chr11:25702679-25702680 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs200347447 | chr11:25702691-25702692 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs541095843 | chr11:25702722-25702723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs528626101 | chr11:25702785-25702786 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs146615077 | chr11:25702789-25702790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs574933754 | chr11:25702794-25702795 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs542097656 | chr11:25702852-25702853 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs112340049 | chr11:25702929-25702930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs564004047 | chr11:25702934-25702935 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs531258280 | chr11:25703044-25703045 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs534389465 | chr11:25703050-25703051 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Burkitt''s lymphoma | 19759907 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Parathyroid adenoma | 22454399 | CNVD |
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastric cancer | 17908304 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Potocki-Shaffer syndrome | 19222835 | CNVD |
WAGR syndrome | 19222835 | CNVD |
Chordoma | 18071362 | CNVD |
Autism | 22102821 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 21364760 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:25698800-25702200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr11:25702200-25703600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr11:25702800-25703600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
4 | chr11:25703000-25703400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr11:25703600-25716200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr11:25705200-25705600 | Enhancers | Fetal Brain Male | brain |
7 | chr11:25713000-25713400 | Enhancers | Brain Germinal Matrix | brain |
8 | chr11:25716200-25718200 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr11:25718200-25718800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
10 | chr11:25718400-25718800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |